Browse Predictions
Explore public, approved predictions by category.
Will the **use of psychedelics** in FDA-approved psychotherapy clinics be legalized in a second U.S. state by 2026?
Forecasting the continued regulatory expansion of psychedelic medicine for mental health treatment.
Will the **World Health Organization (WHO)** launch a major, multi-nation initiative specifically targeting **Air Pollution** as the number one environmental health risk by 2026?
Forecasting an increased focus on the direct, measurable impact of air quality on public health.
Will **Automated Quality Assurance (AQA)** completely replace human quality control in over 90% of global pharmaceutical manufacturing by 2026?
Predicting the complete automation of a critical, high-stakes process in the drug industry.
Will the average life expectancy for **women in the US** drop below 78 years by 2026?
Forecasting a continued decline in US public health outcomes, especially for women, due to chronic disease and external factors.
Will the global number of confirmed **Alzheimer’s cases** begin to decline due to new pharmaceutical interventions by 2026?
Forecasting the first measurable positive effect of new Alzheimer's treatments on disease prevalence.
Will a **therapeutic vaccine** for a chronic viral infection (e.g., HIV, HSV) successfully complete Phase 2 human trials by 2026?
Forecasting a major milestone in infectious disease treatment using next-generation vaccine technology.
Will the **malaria incidence rate** in two or more high-prevalence African countries drop by over 50% due to new vaccines/interventions by 2026?
Forecasting the measurable impact of new malaria vaccines and control efforts.
Will a new **pan-resistant fungal pathogen** lead to a localized public health emergency in a developed nation by 2026?
Forecasting the emergence of a major public health threat due to antimicrobial resistance.
Will the global market for **Personalized Nutrition Apps** and services exceed $10 billion by 2026?
Forecasting the commercial success of data-driven dietary and wellness platforms.
Will a major pharmaceutical company successfully launch a drug based on **RNA interference (RNAi)** technology for a non-hereditary disease by 2026?
Forecasting the clinical success and commercialization of advanced gene-silencing therapies.
Will a drug using CRISPR technology for the treatment of a non-hereditary disease enter Phase III human trials by 2026?
Forecasting the expansion of gene-editing use beyond genetic disorders.
Will the global birth rate fall below 2.0 children per woman by 2026?
Predicting a key demographic milestone for global population change.